Source: International Congress 2015 – IPF: clinical aspects II
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Julie Morisset (San Francisco, United States of America), Julie Morisset, Brett M. Elicker, Xiaowen Hu, Stephanie Le, Jay H. Ryu, Kirk D. Jones, Brett Ley, Paul J. Wolters, Talmadge E. King, Harold R. Collard, Joyce S. Lee. Predictors of mortality and risk prediction among patients with scleroderma related interstitial lung disease. Eur Respir J 2015; 46: Suppl. 59, 4962

Member's Comments

No comment yet.

Related content which might interest you: Addition of respiratory hospitalizations 24weeks prior to the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Co-morbidities and cause of death in patients with rheumatoid arthritis associated interstitial lung disease Source: International Congress 2015 – Connective tissue disorders Year: 2015 Study of factors affecting mortality in ILD cases over 2 years Source: International Congress 2016 – Clinical aspects of ILD Year: 2016 Prognostic factors of interstitial lung disease associated with primary Sjögren's syndrome Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Clinical characteristics of 30 patients with interstitial pneumonia associated with anti-aminoacyl-tRNA-synthetase antibodies Source: International Congress 2016 – Connective tissue disorders Year: 2016 Rituximab in severe, progressive interstitial lung disease Source: International Congress 2016 – Connective tissue disorders Year: 2016 A multicentre evaluation of inter-multidisciplinary team agreement for predicted disease behaviour and management strategy in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Pattern and impact of rheumatology referral in patients with ILD and autoimmune features Source: International Congress 2016 – Connective tissue disorders Year: 2016 Are risk predicting models useful for estimating survival in rheumatoid arthritis-associated interstitial lung disease? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Idiopathic non-specific interstitial pneumonia (iNSIP): do the patients develop connective tissue disease (CTD) during follow-up? Source: International Congress 2016 – Connective tissue disorders Year: 2016 Rituximab in severe, treatment-refractory interstitial lung disease Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 A multicentre evaluation of inter-multidisciplinary team agreement for diagnosis in diffuse lung disease Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases Year: 2016 Characteristics and predictors of outcome in rheumatoid arthritis related ILD Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease Year: 2013 Using the ILD-GAP model to predict mortality in chronic interstitial lung disease Source: International Congress 2015 – IIPs: orphan Year: 2015 Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy Source: International Congress 2014 – ILDs 4 Year: 2014 The prognostic factor in patients with myositis-associated interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD) Source: International Congress 2015 – Connective tissue disorders Year: 2015 The role of detection of myositis specific and associated antibodies in Japanese patient with interstitial lung disease Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Frequency and impact of interstitial lung disease on clinical state and mortality in systemic scleroderma Source: Annual Congress 2012 - Diffuse parenchymal lung disease III Year: 2012 What if my lung-dominant connective tissue disease (LD-CTD) patient eventually met criteria for a definite CTD: The role of prognosis! Source: International Congress 2015 – Connective tissue disorders Year: 2015